FDA Inspection
Rentschler Biopharma Inc.Rentschler Biopharma Inc. – FDA Inspection, Mar 24, 2023
Record Details
This FDA Inspection record concerns Rentschler Biopharma Inc., with an inspection on March 24, 2023, issued by the New England District Office.
- Company
- Rentschler Biopharma Inc.
- Inspection Date
- March 24, 2023
View Company Profile
ID · 677dabb7-4663-4162-b23d-07be45784457
Inspection Facts
- Inspection number
- 1202865
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Rentschler Biopharma Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 10, 2025 | Not classified | New England District Office | |
| January 17, 2025 | Not classified | New England District Office | |
| December 13, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 26, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 23, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Rentschler Biopharma Inc.
- FDA Inspection 1298478 - 2025-12-10
- FDA Inspection 1259307 - 2025-01-17
- FDA Inspection 1116307 - 2019-12-13
- FDA Inspection 1046134 - 2018-03-26
- FDA Inspection 961189 - 2016-02-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.